BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26165609)

  • 1. Antibody against nucleocapsid protein predicts susceptibility to human coronavirus infection.
    Gao X; Zhou H; Wu C; Xiao Y; Ren L; Paranhos-BaccalĂ  G; Guo L; Wang J
    J Infect; 2015 Nov; 71(5):599-602. PubMed ID: 26165609
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of non-pneumonic infections with SARS-correlated virus.
    Theron M
    Lancet; 2004 May; 363(9423):1825; author reply 1826-7. PubMed ID: 15172785
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of non-pneumonic infections with SARS-correlated virus.
    Yip CW; Hon CC; Zeng F; Chow KY; Leung FC
    Lancet; 2004 May; 363(9423):1825; author reply 1826-7. PubMed ID: 15172784
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: implication for SARS diagnosis.
    Sun ZF; Meng XJ
    J Clin Microbiol; 2004 May; 42(5):2351-2. PubMed ID: 15131233
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevalence of non-pneumonic infections with SARS-correlated virus.
    Zhou YH
    Lancet; 2004 May; 363(9423):1825-6; author reply 1826-7. PubMed ID: 15172786
    [No Abstract]   [Full Text] [Related]  

  • 6. Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients.
    Liu X; Shi Y; Li P; Li L; Yi Y; Ma Q; Cao C
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):227-8. PubMed ID: 14715574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins.
    Haynes LM; Miao C; Harcourt JL; Montgomery JM; Le MQ; Dryga SA; Kamrud KI; Rivers B; Babcock GJ; Oliver JB; Comer JA; Reynolds M; Uyeki TM; Bausch D; Ksiazek T; Thomas W; Alterson H; Smith J; Ambrosino DM; Anderson LJ
    Clin Vaccine Immunol; 2007 Mar; 14(3):331-3. PubMed ID: 17229882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein.
    Vlasova AN; Zhang X; Hasoksuz M; Nagesha HS; Haynes LM; Fang Y; Lu S; Saif LJ
    J Virol; 2007 Dec; 81(24):13365-77. PubMed ID: 17913799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43.
    Lee HK; Lee BH; Seok SH; Baek MW; Lee HY; Kim DJ; Na YR; Noh KJ; Park SH; Kumar DN; Kariwa H; Nakauchi M; Heo SJ; Park JH
    J Vet Sci; 2010 Jun; 11(2):165-7. PubMed ID: 20458159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.
    Woo PC; Lau SK; Wong BH; Chan KH; Chu CM; Tsoi HW; Huang Y; Peiris JS; Yuen KY
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):665-8. PubMed ID: 15242938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia.
    Woo PC; Lau SK; Wong BH; Tsoi HW; Fung AM; Chan KH; Tam VK; Peiris JS; Yuen KY
    J Clin Microbiol; 2004 May; 42(5):2306-9. PubMed ID: 15131220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide.
    Woo PC; Lau SK; Wong BH; Chan KH; Hui WT; Kwan GS; Peiris JS; Couch RB; Yuen KY
    J Clin Microbiol; 2004 Dec; 42(12):5885-8. PubMed ID: 15583332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum.
    Chen S; Lu D; Zhang M; Che J; Yin Z; Zhang S; Zhang W; Bo X; Ding Y; Wang S
    Eur J Clin Microbiol Infect Dis; 2005 Aug; 24(8):549-53. PubMed ID: 16133409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of inapparent nosocomial severe acute respiratory syndrome coronavirus infection in Vietnam by use of highly specific recombinant truncated nucleocapsid protein-based enzyme-linked immunosorbent assay.
    Yu F; Le MQ; Inoue S; Thai HT; Hasebe F; Del Carmen Parquet M; Morita K
    Clin Diagn Lab Immunol; 2005 Jul; 12(7):848-54. PubMed ID: 16002634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological differentiation between COVID-19 and SARS infections.
    Chia WN; Tan CW; Foo R; Kang AEZ; Peng Y; Sivalingam V; Tiu C; Ong XM; Zhu F; Young BE; Chen MI; Tan YJ; Lye DC; Anderson DE; Wang LF
    Emerg Microbes Infect; 2020 Dec; 9(1):1497-1505. PubMed ID: 32529906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA.
    Huang LR; Chiu CM; Yeh SH; Huang WH; Hsueh PR; Yang WZ; Yang JY; Su IJ; Chang SC; Chen PJ
    J Med Virol; 2004 Jul; 73(3):338-46. PubMed ID: 15170626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the changing regularity of special antibody and expression of stomach and enteric involvement on SARS-coronavirus infection in the recovery period of severe acute respiratory syndrome].
    Shi YL; Li LH; Sun ZH; Chen JY; Liao Y; Zeng LL; Zhang W; Chen XD; Cao C
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jul; 31(7):795-9. PubMed ID: 21162846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and epitope mapping of monoclonal antibodies to the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
    Kariwa H; Noda H; Nakauchi M; Ishizuka M; Hashiguchi K; Hashimoto S; Yoshii K; Asano A; Agui T; Kogaki H; Kurano Y; Uchida Y; Fujii N; Okada M; Takashima I
    Jpn J Vet Res; 2008 Feb; 55(4):115-27. PubMed ID: 18380153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals.
    Zhang L; Zhang F; Yu W; He T; Yu J; Yi CE; Ba L; Li W; Farzan M; Chen Z; Yuen KY; Ho D
    J Med Virol; 2006 Jan; 78(1):1-8. PubMed ID: 16299724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
    Petrie JG; Bazzi LA; McDermott AB; Follmann D; Esposito D; Hatcher C; Mateja A; Narpala SR; O'Connell SE; Martin ET; Monto AS
    J Infect Dis; 2021 Jul; 224(1):49-59. PubMed ID: 33755731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.